Shiraoka, Japan

Kohzi Nakano


Average Co-Inventor Count = 8.5

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Shiraoka, JA (1976)
  • Ageo, JA (1976)

Company Filing History:


Years Active: 1976

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **The Innovations of Kohzi Nakano: A Beacon in Pharmaceutical Advancement**

Introduction

Kohzi Nakano is a distinguished inventor located in Shiraoka, Japan, whose contributions to the field of pharmaceuticals are noteworthy. With a total of two patents to his name, Nakano has focused his research on developing novel antibacterial compounds that hold significant potential for medical applications.

Latest Patents

Nakano's latest innovations include two groundbreaking patents. The first patent is for “Ampicillin derivatives substituted by heterocyclic acyl group.” This patent details a series of ampicillin derivatives characterized by varied substituents, which are valuable as antibacterial agents. The intricate formula he devised showcases a comprehensive understanding of chemical compounds, highlighting ampicillin's structure and the modifications that enhance its antibacterial properties.

The second patent is for “Novel oxofuryl ester derivatives of penicillin and cephalosporin.” This innovation involves the development of oxofuryl ester derivatives linked to penicillin and cephalosporin classes, which have a heightened absorption rate in the intestines and demonstrate lower toxicity compared to existing alternatives. These compounds are poised to revolutionize oral antibiotic administration, thus improving patient outcomes.

Career Highlights

Kohzi Nakano is affiliated with Yamanouchi Pharmaceutical Company Ltd., a leading name in the pharmaceutical industry. His inventive work continues to pave the way for advancements in antibacterial treatments, and his patents signify remarkable milestones in his professional journey. Nakano’s dedication to innovation serves as an inspiration for emerging scientists and inventors within the field.

Collaborations

During his career, Nakano has had the privilege of collaborating with esteemed colleagues such as Masuo Murakami and Ichiro Isaka. Together, they have worked on various projects and shared knowledge that contributes to the advancement of pharmaceutical science. These collaborations underscore the importance of teamwork in achieving remarkable innovations.

Conclusion

Kohzi Nakano’s contributions to the pharmaceutical sector reflect a commitment to developing effective and safer antibacterial alternatives. His patents not only showcase his inventive spirit but also highlight the potential for future advancements in medical treatments. As the landscape of drug development continues to evolve, Nakano’s work serves as a testament to the impact of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…